The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
Conditions: Cardiotoxicity Induced by Drug Therapy for Breast Cancer Interventions: Drug: Shengmai San (ingredients include ginseng, Ophiopogon japonicus, and Schisandra chinensis) Sponsors: Zhejiang Cancer Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Ginseng | Heart | Herceptin | Hospitals | Research | Toxicology